8 New IPOs for the Week of October 6

Francis Gaskins  |

In order of largest IPO first.  A variety of industries.

(1) Based in London, UK, OM Asset Management Ltd ($OMAM) scheduled a $352 million IPO on NYSE with a market capitalization of $1.9 billion at a price range midpoint of $16 for Thursday, Oct. 9, 2014.

OMAM is a global, diversified, multi-boutique asset management company with approximately $214.9 billion of assets under management as of June 30, 2014.

(2) Based in Kuala Lumpur, Malaysia, MOL Global ($MOLG) scheduled a $267 million IPO on Nasdaq with a market capitalization of $911 million at a price range midpoint of $13.50 for Thursday, Oct. 9, 2014.

MOLG is the largest e-payment enabler for online goods and services in Southeast Asia by payment volume, according to the Frost & Sullivan report.

 (3) Based in Flint, MI, Diplomat Pharmacy ($DPLO) scheduled a $200 million IPO on the NYSE with a market capitalization of $756 million at a price range midpoint of $15 for Friday, Oct. 10, 2014.

DPLO is the nation's largest independent specialty pharmacy and is focused on improving lives of patients with complex chronic diseases.

(4) Based in Cambridge, MA, HubSpot ($HUBS) scheduled a $100 million IPO on NYSE with a market capitalization of $607 million at a price range midpoint of $19-21 for Thursday, Oct. 9, 2014.

HUBS provides a cloud-based marketing and sales software platform that enables businesses to deliver an inbound experience.

(5) Based in Houston, TX, USD Partners LP ($USDP) scheduled a $177 million IPO on NYSE with a market capitalization of $204 million at a price range midpoint of $20 for Thursday, Oct. 9, 2014.

USDP is a fee-based, growth-oriented master limited partnership formed by US Development Group LLC to acquire, develop and operate energy-related rail terminals and other high-quality and complementary midstream infrastructure assets and businesses.

(6) Based in Dallas, TX, Dave & Buster's Entertainment (PLAY) scheduled a $100 million IPO on Nasdaq with a market capitalization of $664 million at a price range midpoint of $17 for Friday, Oct. 10, 2014.

PLAY is a leading owner and operator of high-volume venues in North America that combine dining and entertainment for both adults and families.

(7) Based in Los Angeles, CA, NeuroSigma ($NSIG) scheduled a $50 million IPO on Nasdaq with a market capitalization of $17 million at a price range midpoint of $14 for Thursday, Nov. 9, 2014.

NSIG is a life sciences company focused on developing bioelectronic products with the potential to transform the lives of patients suffering from major neurological and neuropsychiatric disorders such as epilepsy and depression.

(8) Based in Dallas, TX, Veritex Holdings ($VBTX) scheduled a $35 million IPO on Nasdaq with a market capitalization of $118 million at a price range midpoint of $13 for Thursday, October 9, 2014.

VBTX is a bank holding company headquartered in Dallas, Texas.

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
HUBS HubSpot Inc. 155.27 5.54 3.70 961,534 Trade
DPLO Diplomat Pharmacy Inc. 13.49 0.23 1.73 376,201 Trade
PLAY Dave & Buster's Entertainment Inc. 50.71 -0.84 -1.63 954,398 Trade
VBTX Veritex Holdings Inc. 23.70 0.58 2.51 234,309 Trade
OMAM BSIG OM Asset Management plc n/a n/a n/a n/a
USDP USD Partners LP representing limited partner interest 10.78 0.10 0.94 48,206 Trade
MOLG MOL Global Inc ADR (Sponsored) n/a n/a n/a n/a

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Investview Inc

Investview Inc is an investor technology and education company. It provides products that allow the individual investor to find, analyze, track, and manage their portfolio.